Skip to main content
TipRanks
Go Ultimate75% OFF

Eledon Pharmaceuticals (ELDN) Stock Statistics & Valuation Metrics

1,053 Followers

Total Valuation

Eledon Pharmaceuticals has a market cap or net worth of $178.63M. The enterprise value is $259.97M.

Market Cap
$178.63M
Enterprise Value
$259.97M

Share Statistics

Eledon Pharmaceuticals has 84,459,720 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
84,459,720
Owned by Insiders
0.33%
Owned by Institutions
30.31%

Financial Efficiency

Eledon Pharmaceuticals’s return on equity (ROE) is -0.56 and return on invested capital (ROIC) is -55.12%.

Return on Equity (ROE)
-0.56
Return on Assets (ROA)
-0.27
Return on Invested Capital (ROIC)
-55.12%
Return on Capital Employed (ROCE)
-0.55
Revenue Per Employee
0
Profits Per Employee
-1.38M
Employee Count
33
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Eledon Pharmaceuticals is -2.68. Eledon Pharmaceuticals’s PEG ratio is 0.19.

PE Ratio
-2.68
PS Ratio
0.00
PB Ratio
3.48
Price to FCF
-2.28
Price to Operating Cash Flow
-3.10
PEG Ratio
0.19

Income Statement

In the last 12 months, Eledon Pharmaceuticals had revenue of 0 and earned -45.62M in profits. Earnings per share was -0.56.

Revenue
0
Gross Profit
0
Operating Income
-83.25M
Pretax Income
-45.58M
Net Income
-45.62M
EBITDA
-45.27M
Earnings Per Share (EPS)
-0.56

Cash Flow

In the last 12 months, operating cash flow was -78.36M and capital expenditures 0, giving a free cash flow of -78.36M billion.

Operating Cash Flow
-78.36M
Free Cash Flow
-78.36M
Free Cash Flow per Share
-0.68

Dividends & Yields

Eledon Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-43.87%
Earnings Yield
-35.05%

Stock Price Statistics

Beta
1.79
52-Week Price Change
20.17%
50-Day Moving Average
2.56
200-Day Moving Average
3.14
Relative Strength Index (RSI)
38.69
Average Volume (3m)
907.06K

Important Dates

Eledon Pharmaceuticals upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
Apr 01, 2027
Ex-Dividend Date
―

Financial Position

Eledon Pharmaceuticals as a current ratio of 7.40, with Debt / Equity ratio of 0.79%

Current Ratio
7.40
Quick Ratio
7.40
Debt to Market Cap
0.00
Net Debt to EBITDA
0.49
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Eledon Pharmaceuticals has paid 35.00K in taxes.

Income Tax
35.00K
Effective Tax Rate
-0.00

Enterprise Valuation

Eledon Pharmaceuticals EV to EBITDA ratio is -2.55, with an EV/FCF ratio of -2.20.

EV to Sales
0.00
EV to EBITDA
-2.55
EV to Free Cash Flow
-2.20
EV to Operating Cash Flow
-2.20

Balance Sheet

Eledon Pharmaceuticals has $69.67M in cash and marketable securities with $376.00K in debt, giving a net cash position of $69.30M billion.

Cash & Marketable Securities
$69.67M
Total Debt
$376.00K
Net Cash
$69.30M
Net Cash Per Share
$0.82
Tangible Book Value Per Share
$0.33

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Eledon Pharmaceuticals is $8.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$8.25
Price Target Upside
290.07% Upside
Analyst Consensus
Strong Buy
Analyst Count
4
Revenue Growth Forecast
―
EPS Growth Forecast
33.59%

Scores

Smart Score
4
AI Score
43